Position in ACAD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,345,359
+$1,449,334 QoQ
Shares Held
606,536
-2.8% QoQ
Ownership
0.352%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 95%
None 5%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. ACAD ranks #47 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in ACAD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,345,359 | 606,536 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $13,896,025 | 624,260 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $17,688,456 | 662,241 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $14,615,380 | 684,882 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $13,728,289 | 636,453 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,574,261 | 696,825 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $16,237,361 | 884,870 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,748,379 | 763,874 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $12,067,994 | 742,646 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $13,722,962 | 742,183 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $20,261,073 | 647,112 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $12,076,922 | 579,507 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $13,604,699 | 568,046 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,924,537 | 580,475 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $8,330,871 | 523,296 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $15,211,641 | 929,807 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,315,894 | 945,060 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $26,146,481 | 1,079,541 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $27,034,673 | 1,158,298 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $18,749,034 | 1,128,780 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $31,676,218 | 1,298,738 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $62,798,514 | 2,434,051 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $67,654,162 | 1,265,510 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $50,160,288 | 1,216,007 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $105,033,227 | 2,166,974 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $67,262,675 | 1,592,016 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||